Solvonis Therapeutics plc
Status: Publicly traded
Last reviewed: October 2026
Direct answer
Solvonis Therapeutics plc is publicly traded on LSE under the ticker SVNS.L.
Solvonis Therapeutics PLC focuses on the development of therapeutic solutions. The company is engaged in the development of novel small-molecule therapeutics for high-burden central nervous system ("CNS") disorders focusing on addiction and psychiatry.
Can you invest in Solvonis Therapeutics plc?
Yes. Solvonis Therapeutics plc trades publicly on LSE as SVNS.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Solvonis Therapeutics plc
Detailed equity research is provided by MarketSnap.